InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,164.72
(
0.72%
)
US TECH 100
17,534.20
(
0.66%
)
Dow Jones
38,814.71
(
0.36%
)
Brent Oil
82.93
(
-0.24%
)
Bitcoin
63,175.02
(
-1.29%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: CPR1975 post# 29908

Monday, 10/28/2019 6:06:30 PM

Monday, October 28, 2019 6:06:30 PM

Post# of 30990
Anatabloc is about to be bypassed by isomyosmine as MYMD Pharmaceuticals will soon begin a phase 2 FDA study testing it against Hashimoto's Thyroiditis. Should the test be a success, which is very likely, Jonnie will have blown the roof off of the pharmaceutical industry as it will mean he has tamed the ever elusive untreatable immune system diseases.

MYMD has previously announced that it is preparing 4 "preclinical studies focused on additional age-related diseases, virtually all autoimmune diseases, Alzheimer's disease, various cancers and heart disease'.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up